- Home
- KFY vs XENE Comparison
KFY vs XENE Comparison
Compare KFY & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFY
- XENE
- Stock Information
- Founded
- KFY 1969
- XENE 1996
- Country
- KFY United States
- XENE Canada
- Employees
- KFY N/A
- XENE N/A
- Industry
- KFY Diversified Commercial Services
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- KFY Consumer Discretionary
- XENE Health Care
- Exchange
- KFY Nasdaq
- XENE Nasdaq
- Market Cap
- KFY 3.6B
- XENE 3.3B
- IPO Year
- KFY 1999
- XENE 2014
- Fundamental
- Price
- KFY $70.15
- XENE $40.23
- Analyst Decision
- KFY Buy
- XENE Strong Buy
- Analyst Count
- KFY 4
- XENE 7
- Target Price
- KFY $77.00
- XENE $56.00
- AVG Volume (30 Days)
- KFY 302.3K
- XENE 405.9K
- Earning Date
- KFY 03-05-2025
- XENE 02-27-2025
- Dividend Yield
- KFY 2.13%
- XENE N/A
- EPS Growth
- KFY 137.12
- XENE N/A
- EPS
- KFY 4.67
- XENE N/A
- Revenue
- KFY $2,708,790,000.00
- XENE N/A
- Revenue This Year
- KFY N/A
- XENE N/A
- Revenue Next Year
- KFY $5.40
- XENE $1,600.08
- P/E Ratio
- KFY $15.00
- XENE N/A
- Revenue Growth
- KFY N/A
- XENE N/A
- 52 Week Low
- KFY $57.80
- XENE $35.53
- 52 Week High
- KFY $80.64
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- KFY 50.39
- XENE 53.03
- Support Level
- KFY $68.70
- XENE $39.25
- Resistance Level
- KFY $71.99
- XENE $41.40
- Average True Range (ATR)
- KFY 1.15
- XENE 1.26
- MACD
- KFY 0.10
- XENE 0.11
- Stochastic Oscillator
- KFY 41.17
- XENE 66.46
About KFY Korn Ferry
Korn Ferry is a United States-based firm engaged in organizational consulting and management recruitment that helps clients fill mid- to high-level management positions. The company's segment includes Consulting; Digital; Executive Search; Professional Search & Interim; and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The consulting segment aligns organizational structure, culture, performance, development, and people to drive sustainable growth by addressing four fundamental organizational and talent needs. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.